ArticleCureus2026
Association Between Body Mass Index and Breast Cancer Incidence in Non-Hispanic White and Black Women: Methodological Considerations From a Secondary Analysis of the Vitamin D and Omega-3 Trial Cohort.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionObesity and age are established risk factors for breast cancer, but racial differences in the association between body mass index (BMI) and breast cancer incidence remain incompletely understood. This study examined the association between BMI and breast cancer incidence among non-Hispanic White and Black women in the VITamin D and OmegA-3 TriaL (VITAL) cohort and secondarily considered methodological issues that may arise when clinical trial data are analyzed observationally.
methodsWe conducted a secondary observational analysis of women enrolled in the VITAL cohort, treating trial participants as a cohort rather than comparing randomized treatment arms. After excluding men and women of races/ethnicities other than non-Hispanic White or Black, 11,377 women aged 55-90 years at baseline with no previous history of breast cancer were included. Using SAS OnDemand software (SAS Institute, Cary, NC), we examined the association between BMI and the incidence of breast cancer with Cox proportional hazards regression models.
resultsThe study sample of 218 women with breast cancer included 84% non-Hispanic White women (n = 183) and 16% Black women (n = 35). Age and White race were each positively related to incident breast cancer in unadjusted models (both p < 0.001). There was a positive nonlinear relationship between BMI and breast cancer (p = 0.0072, df = 1, x
conclusionBreast cancer incidence showed a nonlinear association with BMI and age, increasing across lower ranges but attenuating at higher BMI levels and older ages. Because this was a secondary analysis of a selected trial cohort, the unexpected attenuation should be interpreted cautiously rather than as evidence of a physiologic plateau.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.